ACE2 and infectious disease: Our studies have defined evACE2 as an innovative decoy therapeutic that efficiently blocks the infectious diseases caused by SARS-CoV-2 and its variants of concern, and presumably all future emerging coronaviruses that utilize ACE2 as their initial tethering receptor.